Effective field theory for the small-x evolution
- 作者I. Balitsky
- 卷第518卷
- 印刷ISSN0370-2693
- 文件大小102.29KB
- 发表时间2001
- DOI10.1016/s0370-2693(01)01041-3
- 页码235-242
New ways to explore factorization in b decaysM. Diehl; G. Hiller · 2001
Prognostic risk factors in advanced Hodgkin's lymphomaM. Loeffler; M. Pfreundschuh; D. Hasenclever; E. Hiller; H. Gerhartz; W. Wilmanns; R. Rohloff; U. Rühl; G. Kühn; R. Fuchs; H. Kirchner; J. Teichmann; W. Schoppe; S. Petsch; W. Wilhelmy; P. Worst; K. H. Pflüger; T. Hecht; H. Bartels; W. Gassmann; G. Krüger; G. Schmitz; W. Oertel; V. Diehl · 1988
Chemotherapy of Hodgkin’s lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study GroupV. Diehl; M. Pfreundschuh; M. Löffler; U. Rühl; E. Hiller; H. Gerhartz; W. Wilmanns; H. Kirchner; W. Schoppe; S. Petsch; H. Bartels; K. H. Pflüger; J. Teichmann; R. Fuchs; G. Kühn; W. Oertel; R. Mertelsmann; T. Hecht; K. P. Schalk; P. Worst; M. Wilhelmy; W. Gassmann; U. Loos; R. Hinterberger; H. Theml; T. Wagner; S. Samandari; W. Schäfgen; J. Preiss; G. Schmitz; W. Mende; B. Mödder; H. D. Schick · 1989